Omicia Closes $23M Series B Financing | GenomeWeb

NEW YORK (GenomeWeb) – Omicia said today that it has completed a $23 million Series B financing round.

Several new investors participated in the round including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large undisclosed genomics investor. Existing investors Artis Ventures, Acadia Woods Partners, and Buchanan Investments also participated in the financing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.